发明名称 Pharmaceutical compositions
摘要 A compound comprising a cyclopentanone, cyclopentenone, cyclohexanone or cyclohexenone group, wherein a first ring carbon atom carries an —SR substituent, R is a substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, or aralkynyl group that, optionally, includes at least one heteroatom in its carbon skeleton, the remaining available ring carbon atoms are optionally substituted, and said compound either: —(a) is more soluble in water at a temperature of 20-40° C.; (b) is less lipophilic; and/or, (c) has a greater therapeutic index; or; (d) is less soluble in water at a temperature of 20-40° C.; (e) is more lipophilic; and/or, (f) has a greater therapeutic index; than an equivalent cyclohex-2-en-1-one or cyclopent-2-en-1-one derivative in which a hydrogen atom replaces said —SR group.
申请公布号 US7759399(B2) 申请公布日期 2010.07.20
申请号 US20040957242 申请日期 2004.09.27
申请人 CRAWFORD HEALTHCARE HOLDINGS LIMITED 发明人 ROBERTS STANLEY MICHAEL;SANTORO MARIA GABRIELLA;JADHAV VASUDEV;HAPPE ALAN MICHAEL;EVANS PAUL;ROSS NICOLETTE CHRISTA;SNAPE TIMOTHY JAMES
分类号 A01N31/00;A23K1/18;A23K1/16;A61K31/222;A61K31/27;A61K31/695;A61P1/02;A61P1/04;A61P1/14;A61P1/16;A61P3/10;A61P9/00;A61P9/08;A61P9/10;A61P11/00;A61P17/02;A61P17/06;A61P17/16;A61P19/08;A61P25/00;A61P25/28;A61P29/00;A61P31/04;A61P31/12;A61P35/00;A61P37/02;A61P39/02;A61P39/06;A61P43/00;C07C323/22;C07C323/59;C07C323/60;C07F7/18 主分类号 A01N31/00
代理机构 代理人
主权项
地址